Approval · Notice of Compliance 1541 · 2000
NOLVADEX: Notice of Compliance 1541
Issued May 9, 2000
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1541
- Date
- May 9, 2000
- Company
- Astrazeneca Canada IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Antineoplastic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NOLVADEX | 02048477 | Cancelled Post Market |
| NOLVADEX-D | 02048485 | Cancelled Post Market |
Medicinal ingredients
- TAMOXIFEN CITRATE 10 MG per TAB
- TAMOXIFEN CITRATE 20 MG per TAB